Nature Communications (Sep 2019)

In vivo epigenetic editing of Sema6a promoter reverses transcallosal dysconnectivity caused by C11orf46/Arl14ep risk gene

  • Cyril J. Peter,
  • Atsushi Saito,
  • Yuto Hasegawa,
  • Yuya Tanaka,
  • Mohika Nagpal,
  • Gabriel Perez,
  • Emily Alway,
  • Sergio Espeso-Gil,
  • Tariq Fayyad,
  • Chana Ratner,
  • Aslihan Dincer,
  • Achla Gupta,
  • Lakshmi Devi,
  • John G. Pappas,
  • François M. Lalonde,
  • John A. Butman,
  • Joan C. Han,
  • Schahram Akbarian,
  • Atsushi Kamiya

DOI
https://doi.org/10.1038/s41467-019-12013-y
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 14

Abstract

Read online

Although many neuropsychiatric risk genes are known to contribute to epigenetic regulation of gene expression, very little is known about specific chromatin-associated mechanisms that govern the formation and maintenance of neuronal connectivity. Here, the authors report that transcallosal connectivity is critically dependent on C11orf46/ARL14EP, a nuclear protein encoded in the chromosome 11p13 WAGR risk locus, and that RNA-guided epigenetic editing of hyperexpressed Sema6a gene promoters in C11orf46-knockdown neurons resulted in normalization of expression and rescue of transcallosal dysconnectivity via repressive chromatin remodeling.